You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Litigation Details for ViiV Healthcare Company v. Gilead Sciences, Inc. (D. Del. 2018)

✉ Email this page to a colleague

« Back to Dashboard

ViiV Healthcare Company v. Gilead Sciences, Inc. (D. Del. 2018)

Docket	⤷ Sign Up	Date Filed	2018-02-07
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Colm Felix Connolly
Jury Demand	Plaintiff	Referred To	Christopher J. Burke
Patents	8,129,385
Link to Docket	External link to docket

Small Molecule Drugs cited in ViiV Healthcare Company v. Gilead Sciences, Inc.

The small molecule drugs covered by the patent cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Details for ViiV Healthcare Company v. Gilead Sciences, Inc. (D. Del. 2018)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2020-02-05	174	Opinion - Memorandum Opinion	infringing United States Patent Number 8,129,385 (the #385 patent). The #385 patent covers pharmaceutical…principle of patent law that the claims of a 2 patent define the…requirements for a patent.") ( citation omitted). It is the claims-not the patent's written description…Bictegravir infringes claims 2 and 6 of the #3 85 patent under the doctrine of equivalents. That doctrine… literally infringe upon the express terms of a patent claim may nonetheless be found to infringe if	External link to document
2020-02-10	176	Notice of Service	Dobkin, M.D. Regarding Infringement of U.S. Patent No. 8,129,385; (3) Reply Expert Report of Jennifer Dressman…Guengerich, Ph.D., Regarding Infringement of U.S. Patent No. 8,129,385; (6) Reply Expert Report of Kenneth M. Merz…Gilead Sciences, Inc.s Infringement of U.S. Patent No. 8,129,385; (7) Supplemental Reply Expert Report of…Gilead Sciences, Inc.s Infringement of U.S. Patent No. 8,129,385; (8) Expert Report of Timothy Simcoe, Ph.D…Gilead Sciences, Inc.s Infringement of U.S. Patent No. 8,129,385 filed by Shionogi & Co., Ltd., ViiV Healthcare	External link to document
2018-02-07	3		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,129,385. (crb) (Entered: …February 2018 1:18-cv-00224-CFC-CJB 830 Patent Plaintiff District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.